Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Are we undervalued here...how about a PE of 2 for this 1/4...

With the update we got from the mid Januaury.... our portion PDS has 3.5 million in cash (this accounts for breakeven results for last 6 weeks of this 1/4 for PDS...).....

We know the MMP has been strengthened by the PTO...

We know we have had an increase in revenue of the MMP...

with sales from PDSG & a 1.1 million dollars write up... and reduced PTSC expenses..(about 25% last 1/4 and reduced lease & operation cost moving forward,,)

If you would use this 1/4 #'s moving forward our current PE is 2.2 ... (Using CNBC's method for calculated PE.. which adds current assets to PE price,,,)

we will have 3.5 million in gain assests this 1/4 ... break even cash and cash equivalents...

(407(shares)/3.5 (gain in assets))* 4 (1/4's)= A * 2.2(our PE) + .05 cents (PTSC assets -Liaabilities per share) .... = our current selleing price.. .12 cents

so if you believe the current MMP strengths will = gain in MMP value then people our undervalued price is even more undervalued...

Share
New Message
Please login to post a reply